Is INmune Bio, Inc. (INMB) a Buy, Sell, or Hold?
NASDAQ : INMB
INmune Bio, Inc. — Competitors
$1.75 USD
-$0.02 (-1.13%)
- Volume
- 225.33K
- Average Volume
- 781.08K
- Market Capitalization
- $46.52M
- P/E Ratio
- -1.04
- Dividend Yield
- 0.00%
- Price Target
- $22.00
- Year High
- $2.96
- Year Low
- $1.09
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.24
INMB vs. The Competition
| Properties | INMB | ALGS | BRNS | CVM |
|---|---|---|---|---|
| Market Cap | $46.52M | $26.18M | $22.79M | $7.97M |
| Shares Outstanding | $26.59M | $6.19M | $40.85M | $6.87M |
| P/E Ratio | -1.04 | -0.49 | -0.43 | -0.33 |
| EPS | -1.56 | -8.68 | -1.28 | -2.79 |
| Day Low | 1.72 | 4.15 | 0.5511 | 1.155 |
| Day High | 1.79 | 4.46 | 0.59 | 1.195 |
| Year Low | 1.09 | 3.98 | 0.512 | 0.89 |
| Year High | 2.96 | 13.689 | 1.83 | 13.48 |
| Average Price 50 | 1.5699 | 5.4044 | 0.65396 | 1.237 |
| Average Price 200 | 1.54393 | 7.39255 | 0.72402 | 4.1317 |
| Volume | 225.33K | 49038 | 11356 | 163.57K |
| Average Volume | - | - | - | - |